8-K 1 eight-k_apr28.htm

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act Of 1934

Date of report (date of earliest event reported): April 28, 2004

  ALARIS MEDICAL SYSTEMS, INC.  

(Exact name of registrant as specified in its charter)

Delaware 1-10207 13-3492624

(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation or organization)   Identification Number)
 

  10221 Wateridge Circle
San Diego, CA 92121-1579
 

(Address, including zip code, of registrant’s principal executive offices)
 

  (858) 458-7000  

Registrant’s telephone number, including area code











Item 12. Results of Operations and Financial Condition

  The following information is being furnished under Item 12, Results of Operations and Financial Condition. Such information, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934:

  On April 28, 2004, ALARIS Medical Systems, Inc. issued the press release attached as Exhibit 99.1, reporting its results for the three months ended March 31, 2004.

SIGNATURES

  Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     
     
    ALARIS MEDICAL SYSTEMS, INC.


Date: April 27, 2004 By: /s/ DAVID L. SCHLOTTERBECK
————————————————
David L. Schlotterbeck
President and Chief Executive Officer



EXHIBIT INDEX

       Exhibit

         99.1          Press release of ALARIS Medical Systems, Inc., dated April 28, 2004, reporting results for the three months ended March 31, 2004.